Mindray and Medtronic Bring Hospital-Grade Monitoring to Outpatient Surgery Centers
Medtronic
Medical Device Manufacturer
With the advancement of medical technology and the increasing pressure to control medical costs, the global healthcare service model is undergoing profound changes. An increasing number of surgeries are shifting from traditional inpatient settings to outpatient settings. This shift not only significantly reduces medical expenses and shortens patient waiting times but also improves the efficiency of medical resource utilization.However, the uniqueness of the outpatient environment (e.g., limited space, flexible equipment deployment requirements, and the need for simple operation) presents new challenges for monitoring devices: how to ensure "hospital-grade" monitoring quality while adapting to the specific needs of outpatient scenarios?
This is particularly important for the U.S. market with Ambulatory Surgery Centers (ASCs). Based on this, to address this bottleneck and keep up with development trends, Mindray North America and Medtronic recently announced an upgrade in their collaboration in the field of patient monitoring, extending from the original hospital settings to U.S. Ambulatory Surgery Centers, to jointly create new value.
Medtronic is one of the absolute leaders in global medical technology, covering multiple fields such as cardiac rhythm management, vascular diseases, neurotechnology, and diabetes management. It holds a 51.2% market share in the U.S., with core patented technologies in monitoring, including Microstream™ end-tidal carbon dioxide monitoring, BIS™ brain function monitoring, Nellcor™ pulse oximetry, and INVOS™ regional oxygen saturation monitoring. Meanwhile, Mindray has strong R&D capabilities and a global market channel in the field of patient monitors, with a mature sales and service network in North America.
The two parties had already established a stable cooperative foundation in the field of acute and critical care, particularly in perioperative monitoring.For example, Mindray integrates systems like the BIS™ Brain Function Monitoring System and INVOS™ Regional Oximetry Technology into its own platform, achieving high-precision physiological monitoring in critical care and perioperative environments. Based on this, the twoSuitable products are expected to be launched as soon as possible in outpatient surgery centers.。
Complete the Map
In the past, advanced monitoring solutions that only large hospitals could use did not seem out of place due to policy-driven cost control and the technical limitations of the time.
As the monitoring environment changes, coupled with the rapid growth of outpatient surgeries driving a huge demand for monitoring equipment, the market for outpatient surgery centers is attracting the attention of many ambitious companies.The two parties accurately captured the market window period brought by the trend of "transition from inpatient to outpatient," and timely entered the ASC market, which might set relevant standards.
The previous integration of Medtronic's monitoring technologies into Mindray's platform was not a simple patchwork but a deep fusion. This time, such integration will be further enhanced, and the result is naturallySignificantly Lower the Threshold for Outpatient Adoption of Advanced Monitoring Technologies, which can also free doctors from the constraints of complex systems and allow them to focus more on patients.
It is reported that Mindray North America is actively promoting the integration of Medtronic's next-generation products, such as the upcoming INVOS™ 7100 system and the new generation BIS™ system, to ensure continuous technological leadership. This indicates that their cooperation has a long history and remains at the forefront.
In terms of channels, both parties utilizeIntegrated Distribution Network, which will promote the procurement and deployment of Mindray monitoring systems equipped with Medtronic technology within the U.S. healthcare system to be more efficient and cost-effective, thereby enabling ambulatory surgery centers to obtain a highly integrated, technologically advanced monitoring solution.
Both parties emphasized the vision of "making advanced monitoring technology more accessible in all clinical scenarios."This collaboration represents the final piece of this vision, equivalent to POCT, capable of being ubiquitous.。
Competitive Point Translocation
From the cooperation case of Mindray and Medtronic, the competition focus of monitoring equipment in the past was parameters, performance, and reliability. Nowadays,Has shifted towards integrating speed, compatibility capabilities, procurement efficiency, and clinical workflow optimization,The primary and secondary points of technical competition have shifted. It is easy to draw a conclusion: Differentiation strategy - achieving win-win outcomes through differentiated collaboration, breaking the deadlock of homogenized price wars.
The advantages of both parties are significant: Medtronic provides high-barrier monitoring modules and clinical recognition, while Mindray offers a scalable platform with strong delivery capabilities, enabling ASCs to possess hospital-grade monitoring capabilities with a lightweight deployment.
This cooperation is a beginning, and Mindray first takes advantage of this environmental trend.，That is, "The trend of surgical scenarios shifting to outpatient settings is becoming increasingly evident, and there is an urgent need for advanced and easily deployable monitoring tools in outpatient care," which will successfully introduce hospital-grade patient monitoring technology into outpatient scenarios.And once the monitoring platform is rolled out on a large scale in ASCs, the recurring revenue potential around consumables, services, and IT connectivity will open up, making the market's potential space imaginable.。
For Mindray, this collaboration further solidifies its position in the U.S. market. Currently, it has partnered with the four major Group Purchasing Organizations (GPOs) in the U.S., covering nearly 10,000 end-user medical institutions across North America. It also covers 80% of IDN healthcare systems and over 2,700 IDN hospitals in the U.S. Medtronic itself already holds a 50% market share as mentioned earlier. If it can successfully tap into the untapped outpatient surgery center market, its standing within the industry will significantly improve.
Next, if the outpatient surgery center'sMedical staff are familiar with and acceptThis integrated system, and the new product portfolio has received approvals from regulatory bodies such as the FDA.PayerIf recognized, this cooperation will be a successful case. Afterwards, it will be promoted to other countries and regions with similar markets and demands.
Written at the end
The shift in monitoring scenarios from inpatient to outpatient care, a transformation in the U.S. healthcare model, is providing Mindray and Medtronic with an opportunity to expand their markets and build differentiated competitive advantages. Given their scale, they are expected to reshape the market landscape.
The collaboration between Mindray and Medtronic represents a synergistic effect of product and channel, with the potential to create ""Hospital-Grade Monitoring for the Masses" TemplateBy deeply integrating technology and platforms, the application threshold for advanced monitoring in outpatient settings has been lowered, making flexible, efficient, and reliable monitoring possible.
The cooperation has also given rise to a highlight, namelyThe focus of competition in the monitoring field is shifting from single-device performance to system integration, workflow optimization, and ecosystem construction.If the vast market of outpatient surgery centers is successfully opened, it will provide a reference for healthcare systems worldwide to address cost and efficiency challenges. Building on the existing strong cooperation with hospitals, this can be achieved by further upgrading technology and optimizing products to target other application scenarios, such as grassroots markets and outpatient markets.
References:
1. Differentiated Collaboration for Win-Win: Medtronic and Mindray Expand into New Outpatient Monitoring Sector, Tongbi Finance, 2026
2. A New Chapter of Strong Collaboration! Mindray North America Deepens Strategic Partnership with Medtronic, Expanding Healthcare Innovation to Ambulatory Surgery Centers Across the U.S., Mindray, 2026
Risk Warning: The stock market involves risks, and investments should be made with caution. The above content is for investors' reference only and should not be regarded as the basis for investment decisions.